ABSCI CORP (ABSI)
(Delayed Data from NSDQ)
$2.91 USD
-0.04 (-1.36%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.91 0.00 (0.00%) 6:24 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ABSI 2.91 -0.04(-1.36%)
Will ABSI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ABSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABSI
Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy?
Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates
ABSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains?
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
Other News for ABSI
Vanguard Group Inc's Strategic Acquisition of Absci Corp Shares
Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on ...
Insider Buying: Andreas Busch Acquires 50,000 Shares of Absci Corp (ABSI)
Absci (ABSI) Receives Price Target Adjustment by Morgan Stanley | ABSI Stock News
Absci (ABSI) Price Target Reduced by Morgan Stanley Amid Public Offering